23.08
price down icon5.60%   -1.37
after-market Handel nachbörslich: 23.46 0.38 +1.65%
loading

Finanzdaten der Sutro Biopharma Inc-Aktie (STRO)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
84.79%
9.693
63.74 17.40 14.81 8.52
Operating Expenses
13.32%
58.15
67.09 85.91 80.07 76.44
Benefits Costs and Expenses
11.58%
66.55
75.26 93.37 84.90 57.31
Costs And Expenses
11.58%
66.55
75.26 93.37 84.90 57.31
Operating Income/Loss
1,349%
-48.46
-3.345 -68.51 -65.26 -67.92
Income/Loss From Continuing Operations Before Tax
393.68%
-56.86
-11.52 -75.97 -70.09 -48.79
Income Tax Expense/Benefit
100.00%
-
-0.018 0.007 2.355 -
Income/Loss From Continuing Operations After Tax
394.45%
-56.86
-11.50 -75.97 -72.44 -48.79
Net Income/Loss
394.45%
-56.86
-11.50 -75.97 -72.44 -48.79
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.34%
84.87
84.58 83.11 1.8945 82.04
Diluted Average Shares
0.34%
84.87
84.58 83.11 1.8945 82.04
Basic Earnings Per Share
378.57%
-0.67
-0.14 -0.91 -0.89 -0.59
Diluted Earnings Per Share
378.57%
-0.67
-0.14 -0.91 -0.89 -0.59
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):